165 related articles for article (PubMed ID: 6100610)
1. The clinical pharmacology of enalapril.
Gomez HJ; Cirillo VJ; Jones KH
J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
[TBL] [Abstract][Full Text] [Related]
2. Enalapril: a review of human pharmacology.
Gomez HJ; Cirillo VJ; Irvin JD
Drugs; 1985; 30 Suppl 1():13-24. PubMed ID: 2994984
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of enalapril.
Abrams WB; Davies RO; Gomez HJ
J Hypertens Suppl; 1984 Dec; 2(2):S31-6. PubMed ID: 6100874
[TBL] [Abstract][Full Text] [Related]
4. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
5. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599
[TBL] [Abstract][Full Text] [Related]
6. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
7. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
Abrams WB; Davies RO; Ferguson RK
Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
9. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Vlasses PH; Larijani GE; Conner DP; Ferguson RK
Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
[TBL] [Abstract][Full Text] [Related]
10. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
Guazzi M; Agostoni P
Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Lantz P; Enghoff E; Hedlund A; Hägg A
Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
14. Enalapril: a new angiotensin converting enzyme inhibitor.
Cleary JD; Taylor JW
Drug Intell Clin Pharm; 1986 Mar; 20(3):177-86. PubMed ID: 3007062
[TBL] [Abstract][Full Text] [Related]
15. [Clinical pharmacology of enalapril in hypertension with chronic renal failure].
Chaignon M; Billaud-Mesguich E; Alexandre JM; Guédon J
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):967-70. PubMed ID: 3026274
[TBL] [Abstract][Full Text] [Related]
16. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Vizir VA; Berezin AE
Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
Kubo SH; Cody RJ
Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
[TBL] [Abstract][Full Text] [Related]
18. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical experience with enalapril in essential hypertension.
Brunner HR; Waeber B; Nussberger J; Schaller MD; Gomez HJ
J Hypertens Suppl; 1983 Oct; 1(1):103-7. PubMed ID: 6100598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
